Nurix Therapeutics
NRIX
NRIX
161 hedge funds and large institutions have $1B invested in Nurix Therapeutics in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 42 reducing their positions, and 31 closing their positions.
Holders
161
Holders Change
-10
Holders Change %
-5.85%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
22
Increased
69
Reduced
42
Closed
31
Calls
$745K
Puts
$173K
Net Calls
+$572K
Net Calls Change
-$109K
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$42.2M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$18.1M |
| 3 |
VPC
3
Vestal Point Capital
New York
|
$22.8M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$12.5M |
| 5 |
5
Morgan Stanley
New York
|
$24.7M |
